Biocon’s Itolizumab Gets DCGI Approval For COVID-19 Treatment

Like
Like Love Haha Wow Sad Angry

Biocon’s Itolizumab Gets DCGI Approval For COVID-19 Treatment  The Drugs Controller General of India (DCGI) approved the use of Biocon’s biologic drug Itolizumab for the treatment of moderate to severe novel coronavirus patients. Biocon said in a BSE filing that DCGI had approved the use of Itolizumab injection 25mg/5mL solution in India for emergency treatment […]

The post Biocon’s Itolizumab Gets DCGI Approval For COVID-19 Treatment  appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/07/itolizumab-for-covid-19-treatment-by-biocon-received-dcgi-approval/

Like
Like Love Haha Wow Sad Angry